PIK3IP1 and hepatocellular carcinoma: Several studies have shown that AKT signaling is aberrantly hyperactivated in HCC by distinct ways including down-regulation of PIK3IP1 (phosphatidylinositol-3-kinase interacting protein I)[13] and overexpression of COX2[30].